AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · see citing works

Targeting multidrug resistance in cancer

Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · see citing works

Mechanisms of Cancer Drug Resistance

Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643 · see citing works

The ErbB signaling network: receptor heterodimerization in development and cancer

Olayioye, M. A., Neve, R. M., Lane, H. A., & Hynes, N. E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,438 · see citing works

The human ATP-binding cassette (ABC) transporter superfamily

Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302 · see citing works

Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.

Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770 · see citing works

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

Cohen, M. H., Williams, G. A., Sridhara, R., Chen, G., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-303 · Cited by 583 · see citing works

Isolation and genetic characterization of human KB cell lines resistant to multiple drugs

Akiyama, S., Fojo, A. T., Hanover, J. A., Pastan, I. H., & Gottesman, M. M. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534700 · Cited by 529 · see citing works

Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521 · see citing works

FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets

Cohen, M. H., Johnson, J. R., Chen, Y., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-461 · Cited by 447 · see citing works

Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429 · see citing works

Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

Dai, C.-L., Tiwari, A. K., Wu, C.-P., Su, X.-D., Wang, S.-R., Liu, D.-G., Ashby, C. R., Huang, Y., Robey, R. W., Liang, Y.-J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0499 · Cited by 386 · see citing works

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity

Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 367 · see citing works

ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics

Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 342 · see citing works

Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

Shi, Z., Peng, X.-X., Kim, I., Shukla, S., Si, Q.-S., Robey, R. W., Bates, S. E., Shen, T., Ashby, C. R., Fu, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2686 · Cited by 315 · see citing works

Multidrug resistance associated proteins in multidrug resistance

Sodani, K. S., Patel, A. S., Kathawala, R. J., & Chen, Z. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10329 · Cited by 304 · see citing works

Complete Characterization of the Human ABC Gene Family

Dean, M. C., & Allikmets, R. L. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012823120935 · Cited by 290 · see citing works

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases

Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274 · see citing works

Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

Tiwari, A. K., Sodani, K. S., Dai, C., Ashby, C. R., & Chen, Z. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211 · see citing works

Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.

Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A. M.-L., Aaronson, S. A., & Kruh, G. D. (1995) · PubMed · Cited by 209 · see citing works

ABCC10, ABCC11, and ABCC12

Kruh, G. D., Guo, Y., Hopper-Borge, E. A., Belinsky, M. G., & Chen, Z. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0114-1 · Cited by 142 · see citing works

ATP-Dependent Efflux of CPT-11 and SN-38 by the Multidrug Resistance Protein (MRP) and Its Inhibition by PAK-104P

Chen, Z., Furukawa, T., Sumizawa, T., Ono, K., Ueda, K., Seto, K., & Akiyama, S.-I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23189-8 · Cited by 135 · see citing works

A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity

Henrich, C. J., Bokesch, H. R., Dean, M. C., Bates, S. E., Robey, R. W., Goncharova, E. I., Wilson, J. A., & McMahon, J. B. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105284576 · Cited by 134 · see citing works

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

Tiwari, A. K., Sodani, K. S., Dai, C.-L., Abuznait, A. H., Singh, S., Xiao, Z., Patel, A. S., Talele, T. T., Fu, L., Kaddoumi, A., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.001 · Cited by 128 · see citing works

Reduced cyclosporin accumulation in multidrug-resistant cells

Goldberg, H. J., Ling, V. W. T., Wong, P. Y., & Skorecki, K. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80073-1 · Cited by 113 · see citing works

Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2

Shukla, S., Sauna, Z. E., & Ambudkar, S. V. (2007) · Leukemia · doi:10.1038/sj.leu.2404897 · Cited by 96 · see citing works

Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function

Zheng, L.-S., Wang, F., Li, Y., Zhang, X., Chen, L., Liang, Y.-J., Dai, C.-L., Yan, Y., Tao, L.-Y., Mi, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005172 · Cited by 92 · see citing works

Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo

Zhao, X.-Q., Xie, J., Chen, X.-G., Sim, H. M., Zhang, X., Liang, Y.-J., Singh, S., Talele, T. T., Sun, Y.-L., Ambudkar, S. V., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076299 · Cited by 92 · see citing works

A common mechanism for ATP hydrolysis in ABC transporter and helicase superfamilies

Geourjon, C., Orelle, C., Steinfels, E., Blanchet, C., Deléage, G., Pietro, A. D., & Jault, J. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01907-7 · Cited by 89 · see citing works

Correction: Reversal of Multidrug Resistance by Lapatinib

(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-24-cor · Cited by 86 · see citing works

QSAR analysis and molecular modeling of ABCG2-specific inhibitors

Nicolle, E., Boumendjel, A., Macalou, S., Genoux‐Bastide, E., Ahmed‐Belkacem, A., Carrupt, P., & Pietro, A. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.10.004 · Cited by 71 · see citing works

Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478

Shi, Z., Tiwari, A. K., Shukla, S., Robey, R. W., Kim, I.-W., Parmar, S., Bates, S. E., Si, Q.-S., Goldblatt, C. S., Abraham, I., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.007 · Cited by 66 · see citing works

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Sodani, K. S., Tiwari, A. K., Singh, S., Patel, A. S., Xiao, Z., Chen, J.-J., Sun, Y.-L., Talele, T. T., & Chen, Z. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.028 · Cited by 61 · see citing works

Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs

Kathawala, R. J., Wang, Y., Ashby, C. R., & Chen, Z. (2013) · 癌症：英文版 · doi:10.5732/cjc.013.10122 · Cited by 56 · see citing works

Evidence for the Role of Glycosylation in Accessibility of the Extracellular Domains of Human MRP1 (ABCC1)

Müller, M., Yong, M., Peng, X.-H., Petre, B., Arora, S., & Ambudkar, S. V. (2002) · Biochemistry · doi:10.1021/bi026075s · Cited by 55 · see citing works

Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)

Deng, W., Dai, C.-L., CHEN, J.-J., Kathawala, R. J., SUN, Y.-L., CHEN, H.-F., Fu, L., & Chen, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2362 · Cited by 54 · see citing works

PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells

Patel, A. S., Tiwari, A. K., Chufán, E. E., Sodani, K. S., Anreddy, N., Singh, S., Ambudkar, S. V., Stephani, R. A., & Chen, Z. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2184-z · Cited by 48 · see citing works

AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo

Xie, H., Lin, L., Tong, L., Jiang, Y., Zheng, M., Chen, Z., Jiang, X., Zhang, X., Ren, X., Qu, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021487 · Cited by 48 · see citing works

Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo

Sodani, K. S., Patel, A. S., Anreddy, N., Singh, S., Yang, D., Kathawala, R. J., Kumar, P., Talele, T. T., & Chen, Z. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.012 · Cited by 47 · see citing works

Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar

Sun, Y.-L., Chen, J.-J., Kumar, P., Chen, K., Sodani, K. S., Patel, A. S., Chen, Y., Chen, S.-D., Jiang, W.-Q., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055576 · Cited by 46 · see citing works

Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10–Mediated Paclitaxel Resistance: A Preclinical Study

Kathawala, R. J., Sodani, K. S., Chen, K., Patel, A. S., Abuznait, A. H., Anreddy, N., Sun, Y.-L., Kaddoumi, A., Ashby, C. R., & Chen, Z. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0743 · Cited by 40 · see citing works

Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP)

Yang, D., Kathawala, R. J., Chufán, E. E., Patel, A. S., Ambudkar, S. V., Chen, Z., & Chen, X. '. (2013) · Future Oncology · doi:10.2217/fon.13.253 · Cited by 29 · see citing works

Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

Kathawala, R. J., Chen, J.-J., Zhang, Y., Wang, Y., Patel, A. S., Wang, D., Talele, T. T., Ashby, C. R., & Chen, Z. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2341 · Cited by 28 · see citing works

Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

SUN, Y.-L., Kathawala, R. J., Singh, S., Zheng, K., Talele, T. T., Jiang, W.-Q., & Chen, Z. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328354a196 · Cited by 25 · see citing works

The Next Generation of Biologic Agents: Therapeutic Role in Relation to Existing Therapies in Metastatic Breast Cancer

Conte, P., & Guarneri, V. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.005 · Cited by 10 · see citing works

The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade

Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 783 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

Wu, S., & Fu, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0775-3 · Cited by 144 · see citing works

Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance

Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A. S., Wurpel, J. N. D., & Chen, Z. (2014) · Molecules · doi:10.3390/molecules190913848 · Cited by 125 · see citing works

LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1

Chang, Z., Jia, Y., Zhang, W., Song, L., Gao, M., Li, M.-J., Zhao, R., Li, J., Zhong, Y., Sun, Q., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0724-4 · Cited by 104 · see citing works

Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study

Wang, Y., Zhang, Y., Zhang, G.-N., Rihani, S. B. A., Wei, M.-N., Gupta, P., Zhang, X., Shukla, S., Ambudkar, S. V., Kaddoumi, A., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.011 · Cited by 76 · see citing works

ABCG2/BCRP: Specific and Nonspecific Modulators

Peña‐Solórzano, D., Stark, S., König, B., Sierra, C. A., & Ochoa‐Puentes, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21428 · Cited by 70 · see citing works

Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells

Gupta, P., Zhang, Y., Zhang, X., Wang, Y., Lu, K. W., Hall, T., Peng, R., Yang, D., Xie, N., & Chen, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487578 · Cited by 67 · see citing works

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

Wang, Y., Zhang, Y., Kathawala, R. J., & Chen, Z. (2014) · Cancers · doi:10.3390/cancers6041925 · Cited by 62 · see citing works

Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo

Zhang, G.-N., Zhang, Y., Wang, Y., Gupta, P., Ashby, C. R., Alqahtani, S., Deng, T., Bates, S. E., Kaddoumi, A., Wurpel, J. N. D., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.040 · Cited by 61 · see citing works

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

Vera, A. A. D., Gupta, P., Lei, Z., Liao, D., Narayanan, S., Teng, Q., Reznik, S. E., & Chen, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.020 · Cited by 59 · see citing works

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1

Wang, Y., Kathawala, R. J., Zhang, Y., Patel, A. S., Kumar, P., Shukla, S., Fung, K. L., Ambudkar, S. V., Talele, T. T., & Chen, Z. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.006 · Cited by 56 · see citing works

Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters

He, Z., Zhao, T., Gong, Y., Zhang, X., Ma, L., & Liu, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112458 · Cited by 55 · see citing works

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

Wu, C., Hsiao, S.-H., & Wu, Y. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101011 · Cited by 47 · see citing works

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors

Zhang, H., Patel, A. S., Wang, Y.-J., Zhang, Y.-K., Kathawala, R. J., Qiu, L., Patel, B. A., Huang, L.-H., Shukla, S., Yang, D., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0511 · Cited by 42 · see citing works

Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway

Lin, J., Feng, J., Yang, H., Yan, Z., Li, Q., Wei, L., Lai, Z., Jin, Y., & Peng, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5892 · Cited by 41 · see citing works

The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs

Wu, C., Hung, T., Lusvarghi, S., Chu, Y.-H., Hsiao, S.-H., Huang, Y.-H., Chang, Y., & Ambudkar, S. V. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114516 · Cited by 41 · see citing works

Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer

Wen-ji, Z., Li, Y., Wei, M.-N., Chen, Y., Qiu, J.-G., Jiang, Q., Yang, Y., Zheng, D.-W., Qin, W.-M., Huang, J.-R., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.011 · Cited by 40 · see citing works

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study

Kathawala, R. J., Wei, L., Anreddy, N., Chen, K., Patel, A. S., Alqahtani, S., Zhang, Y.-K., Wang, Y.-J., Sodani, K. S., Kaddoumi, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2638 · Cited by 36 · see citing works

Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles

Kita, D. H., Guragossian, N., Zattoni, I. F., Moure, V. R., Rego, F. G. D. M., Lusvarghi, S., Moulenat, T., Belhani, B., Picheth, G., Bouacida, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79892-w · Cited by 35 · see citing works

Diverse Targeted Approaches to Battle Multidrug Resistance in Cancer

Shankaraiah, N., Nekkanti, S., Ommi, O., & Soukya, P. S. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410110729 · Cited by 32 · see citing works

Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2

Li, Q., WANG, X., Shen, A., Zhang, Y., Chen, Y., Sferra, T. J., Lin, J., & Peng, J. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2762 · Cited by 33 · see citing works

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDRin vitroandin vivo

Anreddy, N., Patel, A. S., Zhang, Y., Wang, Y., Shukla, S., Kathawala, R. J., Kumar, P., Gupta, P., Ambudkar, S. V., Wurpel, J. N. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5747 · Cited by 28 · see citing works

New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluation

Eissa, I. H., Yousef, R. G., Elkady, H., Alsfouk, A. A., Husein, D. Z., Ibrahim, I. M., El‐Deeb, N. M., Kenawy, A. M. A., Eldehna, W. M., Elkaeed, E. B., et al. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10644-4 · Cited by 25 · see citing works

Recent Development of the Second and Third Generation Irreversible Epidermal Growth Factor Receptor Inhibitors

Han, W., & Du, Y. (2017) · Chemistry & Biodiversity · doi:10.1002/cbdv.201600372 · Cited by 24 · see citing works

Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studies

Dong, X., Zhang, M., Teng, Q., Lei, Z., Cai, C., Wang, J., Wu, Z., Yang, Y., Chen, X., Guo, H., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217309 · Cited by 22 · see citing works

Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance

Zhang, Y., Zhang, Y., Wang, Y., Vispute, S. G., Jain, S. K., Chen, Y., Li, J., Youssef, D. T. A., Sayed, K. A. E., & Chen, Z. (2015) · Marine Drugs · doi:10.3390/md13042267 · Cited by 22 · see citing works

Multidrug Efflux Pumps and Their Inhibitors Characterized by Computational Modeling

Ramaswamy, V. K., Cacciotto, P., Malloci, G., Ruggerone, P., & Vargiu, A. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_30 · Cited by 12 · see citing works

Butorphanol, a synthetic opioid, sensitizes ABCB1-mediated multidrug resistance via inhibition of the efflux function of ABCB1 in leukemia cells

Wen, J., Zhang, T., SHAN, Z.-M., QI, M.-Y., Xiu, H., Liu, L., WU, S.-Z., Jia, Z., & XU, K.-Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4052 · Cited by 6 · see citing works

[Advances in Lung Stem Cells and Lung Cancer Stem Cells].

Yin, H., & Deng, J. (2015) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2015.10.06 · Cited by 3 · see citing works

Mechanistic and Pharmacological Insights into Modulation of ABC Drug Transporters by Tyrosine Kinase Inhibitors

Shukla, S., Patel, A. S., & Ambudkar, S. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-23476-2_10 · Cited by 3 · see citing works

Unveiling the role of MGMT and DAPK hypermethylation in response to anti‐EGFR agents: Molecular insights for advancing HNSCC treatment

Arantes, L. M. R. B., Oliveira, R. J. D. S., de Carvalho, A. C., Melendez, M. E., Sorroche, B. P., Teixeira, R. D. J., Tostes, K., Palmero, E. I., Reis, R. M., & Carvalho, A. L. (2023) · Head & Neck · doi:10.1002/hed.27602 · Cited by 2 · see citing works

BindingDB Entry 50018741: Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters.

BindingDB (2024) · UC San Diego · doi:10.7270/q2r215mn

Evaluating Drug–Drug Interactions by Constructing Advanced Machine Learning Models of ABC Transporter Inhibitors

Carey, S. R., Wen, X., Daood, N. J., Chung, E., Tiley, J. B., Aleksunes, L. M., & Zhu, H. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c02847

ARRY‐334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP‐Binding Cassette Subfamily G Member 2

Wang, D., Patel, A. S., Sim, H., Zhang, Y.-K., Wang, Y., Kathawala, R. J., Zhang, H., Talele, T. T., Ambudkar, S. V., Xu, R., et al. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24787 · Cited by 20 · see citing works

Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

Kathawala, R. J., Chen, J.-J., Zhang, Y., Wang, Y., Patel, A. S., Wang, D., Talele, T. T., Ashby, C. R., & Chen, Z. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2341 · Cited by 28 · see citing works

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Sodani, K. S., Tiwari, A. K., Singh, S., Patel, A. S., Xiao, Z., Chen, J.-J., Sun, Y.-L., Talele, T. T., & Chen, Z. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.028 · Cited by 61 · see citing works

Abstract B112: ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Wang, D., Patel, A. S., Kumar, P., Xu, R., & Chen, Z. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-13-b112

Abstract 777: GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Sodani, K. S., Tiwari, A. K., Singh, S., Patel, A. S., Xiao, Z., Chen, J., Sun, Y.-L., Talele, T. T., & Chen, Z. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-777